CERS has pcodes (with a premium) backing by majority of blood banks, the AABB. ARC will be on board. Pathogen inactivated RBCs would not yield the same storage lifespan but would obsolete current mandatory tests. Cers should have solid growth until RBCs are approved.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。